333 related articles for article (PubMed ID: 32036575)
1. LINAC-based stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy delivered in 3 or 5 fractions for vestibular schwannomas: comparative assessment from a single institution.
Söderlund Diaz L; Hallqvist A
J Neurooncol; 2020 Apr; 147(2):351-359. PubMed ID: 32036575
[TBL] [Abstract][Full Text] [Related]
2. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
[TBL] [Abstract][Full Text] [Related]
3. Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery.
Anderson BM; Khuntia D; Bentzen SM; Geye HM; Hayes LL; Kuo JS; Baskaya MK; Badie B; Basavatia A; Pyle GM; Tomé WA; Mehta MP
J Neurooncol; 2014 Jan; 116(1):187-93. PubMed ID: 24142200
[TBL] [Abstract][Full Text] [Related]
4. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
[TBL] [Abstract][Full Text] [Related]
5. Five-year outcomes following hypofractionated stereotactic radiotherapy delivered in five fractions for acoustic neuromas: the mean cochlear dose may impact hearing preservation.
Chen Z; Takehana K; Mizowaki T; Uto M; Ogura K; Sakanaka K; Arakawa Y; Mineharu Y; Miyabe Y; Mukumoto N; Miyamoto S; Hiraoka M
Int J Clin Oncol; 2018 Aug; 23(4):608-614. PubMed ID: 29556918
[TBL] [Abstract][Full Text] [Related]
6. Image-guided stereotactic radiotherapy for patients with vestibular schwannoma. A clinical study.
Badakhshi H; Muellner S; Wiener E; Budach V
Strahlenther Onkol; 2014 Jun; 190(6):533-7. PubMed ID: 24589920
[TBL] [Abstract][Full Text] [Related]
7. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
[TBL] [Abstract][Full Text] [Related]
8. Hearing Preservation for Vestibular Schwannomas Treated with Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy.
Udawatta M; Kwan I; Preet K; Nguyen T; Ong V; Sheppard JP; Duong C; Romiyo P; Lee P; Tenn S; Kaprealian T; Gopen Q; Yang I
World Neurosurg; 2019 Sep; 129():e303-e310. PubMed ID: 31132496
[TBL] [Abstract][Full Text] [Related]
9. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.
Collen C; Ampe B; Gevaert T; Moens M; Linthout N; De Ridder M; Verellen D; D'Haens J; Storme G
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e503-9. PubMed ID: 21665381
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
[TBL] [Abstract][Full Text] [Related]
11. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome.
Combs SE; Welzel T; Kessel K; Habermehl D; Rieken S; Schramm O; Debus J
Radiother Oncol; 2013 Feb; 106(2):175-80. PubMed ID: 23333012
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
[TBL] [Abstract][Full Text] [Related]
13. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Radiosurgery and Radiation Therapy in the Management of Patients With Vestibular Schwannomas.
Germano IM; Sheehan J; Parish J; Atkins T; Asher A; Hadjipanayis CG; Burri SH; Green S; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E49-E51. PubMed ID: 29309637
[TBL] [Abstract][Full Text] [Related]
14. Fractionated vs. single-fraction stereotactic radiotherapy in patients with vestibular schwannoma : Hearing preservation and patients' self-reported outcome based on an established questionnaire.
Kessel KA; Fischer H; Vogel MM; Oechsner M; Bier H; Meyer B; Combs SE
Strahlenther Onkol; 2017 Mar; 193(3):192-199. PubMed ID: 27803960
[TBL] [Abstract][Full Text] [Related]
15. Hypo-fractionated stereotactic radiotherapy of five fractions with linear accelerator for vestibular schwannomas: A systematic review and meta-analysis.
Nguyen T; Duong C; Sheppard JP; Lee SJ; Kishan AU; Lee P; Tenn S; Chin R; Kaprealian TB; Yang I
Clin Neurol Neurosurg; 2018 Mar; 166():116-123. PubMed ID: 29414150
[TBL] [Abstract][Full Text] [Related]
16. Linac-based stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannomas: comparative observations of 139 patients treated at a single institution.
Puataweepong P; Dhanachai M; Dangprasert S; Narkwong L; Sitathanee C; Sawangsilpa T; Janwityanujit T; Yongvithisatid P
J Radiat Res; 2014 Mar; 55(2):351-8. PubMed ID: 24142966
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas - pooled results from 3 large German centers.
Combs SE; Engelhard C; Kopp C; Wiedenmann N; Schramm O; Prokic V; Debus J; Molls M; Grosu AL
Radiother Oncol; 2015 Mar; 114(3):378-83. PubMed ID: 25702864
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated stereotactic radiotherapy for acoustic neuromas: safety and effectiveness over 8 years of experience.
Sakanaka K; Mizowaki T; Arakawa Y; Araki N; Oya N; Takahashi JA; Mikuni N; Miyamoto S; Hashimoto N; Hiraoka M
Int J Clin Oncol; 2011 Feb; 16(1):27-32. PubMed ID: 20830603
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy using the CyberKnife
Puataweepong P; Dhanachai M; Swangsilpa T; Sitathanee C; Ruangkanchanasetr R; Hansasuta A; Pairat K
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e247-e254. PubMed ID: 34310064
[TBL] [Abstract][Full Text] [Related]
20. Trigeminal neuropathy in vestibular schwannoma: a treatment algorithm to avoid long-term morbidity.
Galloway L; Palaniappan N; Shone G; Hayhurst C
Acta Neurochir (Wien); 2018 Apr; 160(4):681-688. PubMed ID: 29344779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
